Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology

Journal of Immunological Methods

Volumn 294, Issue 1-2, 2004, Pages 111-122

  Huhtinen, Petri ^a   Soukka, Tero ^a   Lövgren, Timo ^a   Härmä, Harri ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Europium(III) nanoparticle label; Immunoassay; Streptavidin biotin technology; Structurally complex analyte; Time resolved fluorometry; Total PSA

Indexed keywords

BIOTIN; CHELATE; EPITOPE; EUROPIUM; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5E4; MONOCLONAL ANTIBODY 5H6; NANOPARTICLE; PROSTATE SPECIFIC ANTIGEN; REAGENT; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY LABELING; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BINDING AFFINITY; BIOTECHNOLOGY; BIOTINYLATION; BLOOD SAMPLING; CHEMICAL STRUCTURE; CORRELATION ANALYSIS; COVALENT BOND; EPITOPE MAPPING; FLUORESCENCE; IMMUNOASSAY; MATERIAL COATING; MICROTITER PLATE ASSAY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIGNAL DETECTION; SURFACE PROPERTY;

ANTIBODIES, MONOCLONAL; BIOTIN; EPITOPES; EUROPIUM; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOSORBENT TECHNIQUES; MALE; MICROSPHERES; PROSTATE-SPECIFIC ANTIGEN; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREPTAVIDIN;

EID: 10344245519     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.09.002     Document Type: Article

References (29)

1. B. Alpha-Bazin, H. Bazin, L. Boissy, and G. Mathis Europium cryptate-tethered ribonucleotide for the labeling of RNA and its detection by time-resolved amplification of cryptate emission Anal. Biochem. 286 2000 17
2. T. Björk, T. Piironen, K. Pettersson, T. Lövgren, U.H. Stenman, J.E. Oesterling, P.A. Abrahamsson, and H. Lilja Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer Urology 48 1996 882
3. M.D. Boisclair, C. McClure, S. Josiah, S. Glass, S. Bottomley, S. Kamerkar, and I. Hemmila Development of a ubiquitin transfer assay for high throughput screening by fluorescence resonance energy transfer J. Biomol. Screen. 5 2000 319
4. W.J. Catalona, D.S. Smith, R.L. Wolfert, T.J. Wang, H.G. Rittenhouse, T.L. Ratliff, and R.B. Nadler Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening JAMA 274 1994 1214
5. M.A. Chan, A.C. Bellem, and E.P. Diamandis Time-resolved immunofluorometric assay of alpha-fetoprotein in serum and amniotic fluid, with a novel detection system Clin. Chem. 33 1987 2000
6. R. Ekins, F. Chu, and J. Micallef High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays J. Biolumin. Chemilumin. 4 1989 59
7. N.M. Green Avidin and streptavidin Methods Enzymol. 184 1990 51
8. G.T. Hermanson Bioconjugate Techniques 1996 Academic Press San Diego, CA
9. H. Härmä, T. Soukka, S. Lönnberg, J. Paukkunen, P. Tarkkinen, and T. Lövgren Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence Luminescence 15 2000 351
10. H. Härmä, T. Soukka, and T. Lövgren Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen Clin. Chem. 47 2001 561
11. J. Leinonen, T. Lövgren, T. Vornanen, and U.-H. Stenman Double-label time-resolved immunofluorometric assay of prostate-specific antigen and its complex with alpha 1-antichymotrypsin Clin. Chem. 39 1993 2098
12. J. Leinonen, P. Wu, and U.-H. Stenman Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries Clin. Chem. 48 2002 2208
13. L.Y. Luo, and E.P. Diamandis Preliminary examination of time-resolved fluorometry for protein array applications Luminescence 15 2000 409
14. J. Lövgren, T. Piironen, C. Overmo, B. Dowell, M. Karp, K. Pettersson, H. Lilja, and A. Lundwall Production of recombinant PSA and hK2 and analysis of their immunological cross-reactivity Biochem. Biophys. Res. Commun. 213 1995 888
15. P. Nurmikko, V. Vaisanen, T. Piironen, S. Lindgren, H. Lilja, and K. Pettersson Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA Clin. Chem. 46 2000 1610
16. L.D. Papsidero, M.C. Wang, L.A. Valenzuela, G.P. Murphy, and T.M. Chu A prostate antigen in sera of prostatic cancer patients Cancer Res. 40 1980 2428
17. 1-antichymotrypsin complex Clin. Chem. 41 1995 1480
18. Q.-P. Qin, T. Lövgren, and K. Pettersson Development of highly fluorescent detection reagents for the construction of ultrasensitive immunoassays Anal. Chem. 73 2001 1521
19. R. Santacroce, A. Ratti, F. Caroli, B. Foglieni, A. Ferraris, L. Cremonesi, M. Margaglione, M. Seri, R. Ravazzolo, G. Restagno, B. Dallapiccola, E. Rappaport, E.S. Pollak, S. Surrey, M. Ferrari, and P. Fortina Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology Clin. Chem. 48 2002 2124
20. V. Santala, and U. Lamminmäki Production of a biotinylated single-chain antibody fragment in the cytoplasm of Escherichia coli J. Immunol. Methods 284 2004 165
21. T. Soukka, J. Paukkunen, H. Härmä, S. Lönnberg, H. Lindroos, and T. Lövgren Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology Clin. Chem. 47 2001 1269
22. T. Soukka, H. Härmä, J. Paukkunen, and T. Lövgren Utilization of kinetically enhanced monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates Anal. Chem. 73 2001 2254
23. T. Soukka, K. Antonen, H. Harma, A.-M. Pelkkikangas, P. Huhtinen, and T. Lovgren Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology Clin. Chim. Acta 328 2003 45
24. U.-H. Stenman, E. Paus, W.J. Allard, I. Andersson, C. Andrès, T.R. Barnett, C. Becker, A. Belenky, L. Bellanger, C.M. Pellegrino, O.P. Børmer, G. Davis, B. Dowell, L.S. Grauer, D.C. Jette, B. Karlsson, F.T. Kreutz, T.M. van der Kwast, L. Lauren, M. Leinimaa, J. Leinonen, H. Lilja, H.J. Linton, M. Nap, O. Nilsson, P.C. Ng, K. Nustad, A. Peter, K. Pettersson, T. Piironen, J. Rapp, H.G. Rittenhouse, P.D. Rye, P. Seguin, J. Slota, R.L. Sokoloff, M.R. Suresh, D.L. Very, T.J. Wang, I. Wigheden, R.L. Wolfert, K.K. Yeung, W-M. Zhang, Z. Zhou, and J. Hilgers Summary report of the TD-3 Workshop: characterization of 83 antibodies against prostate-specific antigen Tumor Biol. 20 Suppl. 1 1999 1
25. M.C. Wang, L.D. Papsidero, M. Kuriyama, L.A. Valenzuela, G.P. Murphy, and T.M. Chu Prostate antigen: a new potential marker for prostate cancer Prostate 2 1981 89
26. M. Wilchek, and E.A. Bayer Applications of avidin-biotin technology: literature survey Methods Enzymol. 184 1990 14
27. M. Wilchek, and E.A. Bayer Editorial. Foreword and introduction to the book (strept)avidin-biotin system Biomol. Eng. 16 1999 1
28. B.O. Villoutreix, E.D. Getzoff, and J.H. Griffin A structural model for the prostate disease marker prostate-specific antigen Protein Sci. 3 1994 2033
29. B.O. Villoutreix, H. Lilja, K. Pettersson, T. Lovgren, and O. Teleman Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building Protein Sci. 5 1996 836